← Back to Search


Neurostimulation for Autism Spectrum Disorder

Research Sponsored by Christiana Care Health Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up at baseline and 5 weeks of rtms
Awards & highlights

Study Summary

This trial will test whether transcranial direct current stimulation (tDCS) can help people with ASD by improving social cognition and communication skills.

Who is the study for?
This trial is for individuals who meet the criteria for Autism Spectrum Disorder (ASD) as per the DSM-V and confirmed by GADS, with an ability to understand and cooperate during procedures. It excludes those with severe anxiety or contact avoidance, a history of seizures, metallic implants in head/neck, or pregnant women.Check my eligibility
What is being tested?
The study explores Trans Cranial Magnetic Stimulation (TMS) as a neurostimulation method to improve social interaction and cognitive functions in people with ASD. The aim is to find an effective treatment beyond current medications that only address some behavioral issues.See study design
What are the potential side effects?
While not explicitly stated here, TMS can sometimes cause discomfort at the stimulation site, headache, lightheadedness, or tingling sensations. Rarely it might induce seizures or affect hearing if proper ear protection isn't used.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and 5 weeks of rtms
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 5 weeks of rtms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The effects of rTMS on reciprocal rigid patterns of behavior
The effects of rTMS on reciprocal social cognition
Secondary outcome measures
The effect of rTMS on verbal fluency
The effects of rTMS on executive function

Trial Design

2Treatment groups
Active Control
Group I: right IPL stimulationActive Control1 Intervention
half of the subjects will receive TMS on the right inferior parietal lobule.
Group II: left IPL stimulationActive Control1 Intervention
half of the subjects will receive TMS on the left inferior parietal lobule.

Find a Location

Who is running the clinical trial?

Christiana Care Health ServicesLead Sponsor
114 Previous Clinical Trials
105,621 Total Patients Enrolled
Dupont Applied BiosciencesIndustry Sponsor
11 Previous Clinical Trials
2,854 Total Patients Enrolled

Media Library

Trans Cranial Magnetic Stimulation (Neurostimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05371912 — N/A
Autism Spectrum Disorder Research Study Groups: right IPL stimulation, left IPL stimulation
Autism Spectrum Disorder Clinical Trial 2023: Trans Cranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05371912 — N/A
Trans Cranial Magnetic Stimulation (Neurostimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05371912 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available to participate in this trial?

"Reference to clinicaltrials.gov shows that, as of May 10th 2022, this medical experiment is actively searching for participants. It was originally posted on March 15th 2021."

Answered by AI

What is the current cohort size of this research?

"Affirmative. According to the records posted on clinicaltrials.gov, this medical trial which was initially announced on March 15th 2022 is actively recruiting participants. 30 volunteers are sought from a single centre for participation in the study."

Answered by AI

Is this research endeavor accommodating participants older than 50?

"The age eligibility for this clinical trial ranges from 5 to 25 years old."

Answered by AI

May I be eligible to take part in this experiment?

"This investigation will involve 30 individuals aged 5-25 who are diagnosed with autism spectrum disorder (ASD) based on the Diagnostic and Statistical Manual for Mental Disorders 5th edition (DSM-V). Additionally, these participants must be willing to cooperate in order to qualify."

Answered by AI
~10 spots leftby Apr 2025